Literature DB >> 25165023

Development and validation of a highly sensitive LC-MS/MS method for the determination of dexamethasone in nude mice plasma and its application to a pharmacokinetic study.

Yin Yuan1, Xuan Zhou, Jian Li, Suofu Ye, Xiwei Ji, Liang Li, Tianyan Zhou, Wei Lu.   

Abstract

In the current study, a simple, sensitive and rapid analytical method for the determination of dexamethasone was developed and applied to a pharmacokinetic study in nude mice. Using testosterone as an internal standard, a liquid chromatography-tandem mass spectrometry (LC-MS/MS) approach after one-step precipitation with acetonitrile was validated and used to determine the concentrations of dexamethasone in nude mice plasma. The method utilized a simple isocratic reverse phase separation over a Dionex C18 column with a mobile phase composed of acetonitrile-water (40:60, v/v). The analyte was detected by a triple quadrupole tandem mass spectrometer via electrospray and multiple reaction monitoring was employed to select both dexamethasone at m/z 393.0/147.1 and testosterone at m/z 289.5/97.3 in the positive ion mode. The calibration curves were linear (r >0.99) ranging from 2.5 to 500 ng/mL with a lower limit of quantitation of 2.5 ng/mL. The relative standard deviation ranged from 1.69 to 9.22% while the relative error ranged from -1.92 to -8.46%. This method was successfully applied to a preclinical pharmacokinetic study of dexamethasone and its pharmacokinetics was characterized by a two-compartment model with first-order absorption in female nude mice.
Copyright © 2014 John Wiley & Sons, Ltd.

Entities:  

Keywords:  LC-MS/MS; dexamethasone; nude mice; pharmacokinetics

Mesh:

Substances:

Year:  2014        PMID: 25165023     DOI: 10.1002/bmc.3316

Source DB:  PubMed          Journal:  Biomed Chromatogr        ISSN: 0269-3879            Impact factor:   1.902


  5 in total

1.  Core shell stationary phase for a novel separation of some COVID-19 used drugs by UPLC-MS/MS Method: Study of grapefruit consumption impact on their pharmacokinetics in rats.

Authors:  Sally Tarek Mahmoud; Marwa A Moffid; Rawda M Sayed; Eman A Mostafa
Journal:  Microchem J       Date:  2022-07-15       Impact factor: 5.304

2.  Time-dependent pharmacokinetics of dexamethasone and its efficacy in human breast cancer xenograft mice: a semi-mechanism-based pharmacokinetic/pharmacodynamic model.

Authors:  Jian Li; Rong Chen; Qing-Yu Yao; Sheng-Jun Liu; Xiu-Yun Tian; Chun-Yi Hao; Wei Lu; Tian-Yan Zhou
Journal:  Acta Pharmacol Sin       Date:  2017-11-09       Impact factor: 6.150

3.  Across-species meta-analysis of dexamethasone pharmacokinetics utilizing allometric and scaling modeling approaches.

Authors:  Dawei Song; William J Jusko
Journal:  Biopharm Drug Dispos       Date:  2021-03-17       Impact factor: 1.627

4.  A combined assay for quantifying remdesivir and its metabolite, along with dexamethasone, in serum.

Authors:  Andrew Reckers; Alan H B Wu; Chui Mei Ong; Monica Gandhi; John Metcalfe; Roy Gerona
Journal:  J Antimicrob Chemother       Date:  2021-04-17       Impact factor: 5.790

5.  Engineering constructed of high selectivity dexamethasone aptamer based on truncation and mutation technology.

Authors:  Yadi Qin; Yanan Qin; Hayilati Bubiajiaer; Fengxia Chen; Jun Yao; Minwei Zhang
Journal:  Front Bioeng Biotechnol       Date:  2022-09-13
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.